Phosphorylation: Different phosphorylation pro-cessses are important for regulating Notch2 activity. Only GSK3beta has been found to phos-phorylate Notch2 in 32D-myeloid cells. Glycosylation: fringe glycosyl-transferases modify the extracellular domain of Notch2 by glycosylation.
Expression
Expressed in the brain, heart, kidney, spleen (hematopoietic cells,T-cells, B-cells and mast cells), lung, intestine, skeletal muscle and liver (hepatic cells and bile duct cells), ameloblasts.
Localisation
Type I membrane protein. Following proteolytical processing it is translocated to the nucleus.
Function
Physiological receptor for membrane-bound ligands jagged1, jagged2 and delta1 to regulate cell-fate determination. Upon ligand activation, Notch intracellular domain forms a transcriptional activator complex with RBP-j kappa and Mastermind proteins and activates genes of the hairy/enhancer of split (hes) family. Notch2 behaves very similar to Notch1 at the biochemical level, and in fact, C-terminal intracellular region of Notch1 can functionally replace that of Notch2 in vivo. However specific functions, specific expres-sion patterns and embryonic lethality of single mutant mice indicate that both proteins are not redundant. Biological functions strictly associated to Notch2 are: Development of kidney (proximal nephron struc-tures: podocytes and proximal convoluted tubules). B-cell differentiation: involved in the final stages of Bcell maturation at the marginal zone of the spleen and expression of CD23 in B-CLL (B-Cell Chronic Lymphoblastic leukaemia). T-cell maturation: later stages of T cell development, induction of CD8+ cells. Notch2 is also required for formation of the placental circulatory system.
Homology
Degree of amino acid identity between Notch1 and Notch2 proteins: overall, 56%; EGF-like repeats, 58%; LNR,58%; CDC10, 76% and PEST, 79%.
Mutations

Germinal
Two different mutations segregating in two families affected by Alagille syndrome: One mutation results in partial deletion of the intracellular domain including 4 ankyrin repeats, the second mutation affects EGF repeat 11.
Implicated in
Alagille syndrome (AGS)
Disease Alagille syndrome (AGS) is a dominant multi-system disorder defined clinically by bile duct paucity and cholestasis in association with cardiac, skeletal and ophthalmologic manifestations with less-frequent clinical involvement of renal and vascular systems. 94% of affected individuals have mutations in the Jagged1 gene. Oncogenesis Notch2 intracellular domain (active Notch2) has neoplastic transformation capacities.
B-Cell Chronic Lymphoblastic Leukemia (B-CLL)
Oncogenesis Function: upregulation of CD23, which has been correlated with high cell viability and inhibition of apoptosis in B-CLL. 
Embryonal brain tumors, medulloblastoma
Melanoma
Oncogenesis Amplification of 1p12 in melanoma cell lines
Lung carcinoma
Oncogenesis Amplification in 9 of 12 samples of squamous lung carcinoma.
Breast carcinoma
Oncogenesis
Putative role of Notch2 as tumor suppressor since upregulation of its expression is associated with survival, and activated Notch2 induces apoptosis in breast cancer xenografts.
